| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;60:1845-1853
© 1995 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery, Division of Pulmonary Medicine, and Department of Pathology, Stanford University School of Medicine, Stanford, California
Obliterative bronchiolitis (OB) has emerged as the main cause of morbidity and mortality in the long-term follow-up after lung and heart-lung transplantation. The pathogenesis of OB is multifactorial, with acute rejection and cytomegalovirus infection being the main risk factors for the development of OB. The final common pathway of all inciting events seems to be an alloimmune injury, with subsequent release of immunologic mediators and production of growth factors leading to luminal obliteration and fibrous scarring of the small airways. Analyzing the 14 years of experience in 163 patients at Stanford University, we found a current incidence of bronchiolitis obliterans syndrome or histologically proven OB within the first 3 years after lung and heart-lung transplantation of 36.3%, with an overall prevalence of 58.1% after heart-lung and 51.4% after lung transplantation. Both pulmonary function indices (forced expiratory flow between 25% and 75% of forced vital capacity and forced expiratory volume in 1 second) and transbronchial biopsies have proven helpful in diagnosing bronchiolitis obliterans syndrome or OB at an early stage. Early diagnosis of OB and improved management have achieved survival rates in patients with OB after 1, 3, 5, and 10 years of 83%, 66%, 46%, and 22%, compared with 86%, 83%, 67%, and 67% in patients without OB. Recently, different experimental models have been developed to investigate the cellular and molecular events leading to OB and to evaluate new treatment strategies for this complication, which currently limits the long-term success of heart-lung and lung transplantation.
This article has been cited by other articles:
|
|
 |
|
  V. N. Lama, S. Murray, R. J. Lonigro, G. B. Toews, A. Chang, C. Lau, A. Flint, K. M. Chan, and F. J. Martinez Course of FEV1 after Onset of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1192 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Moffatt-Bruce, J. Karamichalis, R. C. Robbins, R. I. Whyte, J. Theodore, and B. A. Reitz Are Heart-Lung Transplant Recipients Protected From Developing Bronchiolitis Obliterans Syndrome? Ann. Thorac. Surg., January 1, 2006; 81(1): 286 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Gerhardt, J. F. McDyer, R. E. Girgis, J. V. Conte, S. C. Yang, and J. B. Orens Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 121 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. V. Naidu, A. S. Farivar, B. Krishnadasan, S. M. Woolley, D. J. Grainger, E. D. Verrier, and M. S. Mulligan Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis Ann. Thorac. Surg., April 1, 2003; 75(4): 1118 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.M. Verleden, L.J. Dupont, M. Delcroix, D. Van Raemdonck, J. Vanhaecke, T. Lerut, and M. Demedts Exhaled nitric oxide after lung transplantation: impact of the native lung Eur. Respir. J., March 1, 2003; 21(3): 429 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pietrantoni, O. A. Minai, N. C. Yu, J. R. Maurer, M. T. Haug III, A. C. Mehta, and A. C. Arroliga Respiratory Failure and Sepsis Are the Major Causes of ICU Admissions and Mortality in Survivors of Lung Transplants Chest, February 1, 2003; 123(2): 504 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hadjiliadis, R. D. Davis, and S. M. Palmer Is Transplant Operation Important in Determining Posttransplant Risk of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients? Chest, October 1, 2002; 122(4): 1168 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Elssner, F. Jaumann, W-P. Wolf, M. Schwaiblmair, J. Behr, H. Furst, H. Reichenspurner, J. Briegel, J. Niedermeyer, and C. Vogelmeier Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection? Eur. Respir. J., July 1, 2002; 20(1): 165 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. ALHO, K. A. INKINEN, U.-S. SALMINEN, P. K. MAASILTA, E. I. TASKINEN, V. GLUMOFF, E. I. VUORIO, T. S. IKONEN, and A. L. J. HARJULA Collagens I and III in a Porcine Bronchial Model of Obliterative Bronchiolitis Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1519 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-S. Lee, M. B. Gotway, G. P. Reddy, J. A. Golden, F. M. Keith, and W. R. Webb Early Bronchiolitis Obliterans Following Lung Transplantation: Accuracy of Expiratory Thin-Section CT for Diagnosis Radiology, August 1, 2000; 216(2): 472 - 477. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. I. Reznik, A. Jaramillo, L. Zhang, G. A. Patterson, J. D. Cooper, and T. Mohanakumar ANTI-HLA ANTIBODY BINDING TO HLA CLASS I MOLECULES INDUCES PROLIFERATION OF AIRWAY EPITHELIAL CELLS: A POTENTIAL MECHANISM FOR BRONCHIOLITIS OBLITERANS SYNDROME J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Harringer, K. Wiebe, M. Struber, U. Franke, J. Niedermeyer, H. Fabel, and A. Haverich Lung transplantation--10-year experience. Eur. J. Cardiothorac. Surg., November 1, 1999; 16(5): 546 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Whyte, R. C. Robbins, J. Altinger, C. W. Barlow, R. Doyle, J. Theodore, and B. A. Reitz Heart-lung transplantation for primary pulmonary hypertension Ann. Thorac. Surg., April 1, 1999; 67(4): 937 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Haverich Experience with lung transplantation Ann. Thorac. Surg., February 1, 1999; 67(2): 305 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jeppsson, C. Pellegrini, T. O'Brien, V. M. Miller, H. D. Tazelaar, and C. G.A. McGregor Transbronchial gene transfer of endothelial nitric oxide synthase to transplanted lungs Ann. Thorac. Surg., August 1, 1998; 66(2): 318 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. L. Lee, F. M. Wagner, M.-F. Chen, C. Serrick, A. Giaid, and H. Shennib A novel charcoal-induced model of obliterative bronchiolitis-like lesions: Implications of chronic nonspecific airway inflammation in the development of posttransplantation obliterative bronchiolitis J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 822 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Herold, H. Jakob, M. Kamler, R. Thiele, U. Tochtermann, J. Weinmann, J. Motsch, M. M. Gebhard, and S. Hagl Interruption of bronchial circulation leads to a severe decrease in peribronchial oxygen tension in standard lung transplantation technique Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 176 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Novick, L. W. Stitt, K. Al-Kattan, W. Klepetko, H.-J. Schafers, J.-P. Duchatelle, A. Khaghani, R. L. Hardesty, G. A. Patterson, and M. H. Yacoub Pulmonary Retransplantation: Predictors of Graft Function and Survival in 230 Patients Ann. Thorac. Surg., January 1, 1998; 65(1): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Whyte, S. J. Rossi, M. S. Mulligan, R. Florn, L. Baker, S. Gupta, F. J. Martinez, and J. P. Lynch III Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation Ann. Thorac. Surg., October 1, 1997; 64(4): 945 - 948. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Bavaria, R. Kotloff, H. Palevsky, B. Rosengard, J. R. Roberts, P. M. Wahl, N. Blumenthal, C. Archer, and L. R. Kaiser BILATERAL VERSUS SINGLE LUNG TRANSPLANTATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 520 - 528. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Novick, L. Stitt, H.-J. Schafers, B. Andreassian, J.-P. Duchatelle, W. Klepetko, R. L. Hardesty, A. Frost, and G. A. Patterson PULMONARY RETRANSPLANTATION: DOES THE INDICATION FOR OPERATION INFLUENCE POSTOPERATIVE LUNG FUNCTION? J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1504 - 1514. [Abstract] [Full Text]
|
|
|
|
|
|
H. Reichenspurner, R. E. Girgis, R. C. Robbins, K. L. Yun, M. Nitschke, G. J. Berry, R. E. Morris, J. Theodore, and B. A. Reitz Stanford Experience With Obliterative Bronchiolitis After Lung and Heart-Lung Transplantation Ann. Thorac. Surg., November 1, 1996; 62(5): 1467 - 1472. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Baudet, C. Dromer, J. Dubrez, J. B. Jougon, X. Roques, J.-F. Velly, C. Deville, L. Couraud, and T. B. L. a. H.-L. T. Group INTERMEDIATE-TERM RESULTS AFTER EN BLOC DOUBLE-LUNG TRANSPLANTATION WITH BRONCHIAL ARTERIAL REVASCULARIZATION J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1292 - 1300. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
